{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:47:00Z","timestamp":1792000020124,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Cannabis sativa<\/jats:italic>\n                    L. produces a chemically diverse array of over 150 phytocannabinoids, of which cannabichromene (CBC) represents the fourth most abundant constituent in many chemovars, yet remains profoundly underexplored relative to its structural congeners delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and its precursor cannabigerol (CBG). Unlike THC, CBC is non-psychoactive and lacks the intoxicating central effects associated with THC, positioning it as a particularly attractive candidate for therapeutic development. This comprehensive review critically examines the current state of knowledge on CBC, encompassing its biosynthetic origin through the polyketide and mevalonate\/methylerythritol phosphate pathways, the enzymatic conversion of cannabigerolic acid (CBGA) to cannabichromenic acid (CBCA) by CBC synthase (CBCAS), and subsequent spontaneous and thermally accelerated decarboxylation. We survey the natural occurrence and distribution of CBC across Cannabis chemovars, the genetic and environmental determinants of its accumulation, and the advanced extraction, isolation, and analytical methodologies employed for its characterization. The pharmacokinetic profile of CBC, including absorption, distribution, hepatic metabolism via cytochrome P450 enzymes, and elimination, is discussed in the context of its notably low oral bioavailability. The molecular pharmacology of CBC is examined in depth, highlighting its unique receptor interaction profile: minimal direct engagement with CB1\/CB2 cannabinoid receptors, potent agonism at transient receptor potential channels (TRPV1, TRPA1, TRPV3, TRPV4), and indirect modulation of endocannabinoid tone through inhibition of anandamide reuptake. We evaluate the preclinical evidence supporting its anti-inflammatory, analgesic, antimicrobial, anticancer, neuroprotective, antidepressant, and dermatological activities, and contextualize these findings within the entourage effect framework. The toxicological safety profile, drug\u2013drug interaction potential, and regulatory landscape are critically assessed. Finally, we identify translational challenges, including formulation limitations, the absence of clinical trials, and regulatory fragmentation, and propose future research directions encompassing nanotechnology-based delivery systems, synthetic biology platforms for sustainable production, multi-omics integration, and precision medicine approaches. This review establishes CBC as a high-potential but critically understudied phytocannabinoid deserving of accelerated preclinical and clinical investigation.\n                  <\/jats:p>","DOI":"10.1186\/s42238-026-00454-4","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:05:38Z","timestamp":1784217938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cannabichromene (CBC): a comprehensive review of biosynthesis, pharmacology, therapeutic potential, and translational perspectives"],"prefix":"10.1186","volume":"8","author":[{"given":"Amine","family":"Elbouzidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellah","family":"Baraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounir","family":"Haddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoufal","family":"El Hachlafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Aqlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"AL-Farga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Taibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Bellaouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdeslam","family":"Asehraou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Addi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"454_CR1","doi-asserted-by":"publisher","unstructured":"Aare M, Padakanti SC, Bagde A, Lazarte JM, Dev S, Lewis C, et al. Pharmacokinetic studies and synergistic antitumor effects of cannabichromene and cannabidiol in drug-resistant breast cancers. Drug Deliv Transl Res. 2026;1\u201321. https:\/\/doi.org\/10.1007\/s13346-026-02057-1.","DOI":"10.1007\/s13346-026-02057-1"},{"key":"454_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159658","author":"CF Almeida","year":"2025","unstructured":"Almeida CF, Correia-Da-Silva G, Ribeiro AP, Teixeira N, Amaral C. Impact of minor cannabinoids on key pharmacological targets of estrogen receptor-positive breast cancer. Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2025. https:\/\/doi.org\/10.1016\/j.bbalip.2025.159658.","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acschemneuro.0c00677","volume":"12","author":"LL Anderson","year":"2021","unstructured":"Anderson LL, Ametovski A, Luo JL, Everett-Morgan D, McGregor IS, Banister SD, et al. Cannabichromene, related phytocannabinoids, and 5-fluoro-cannabichromene have anticonvulsant properties in a mouse model of Dravet syndrome. ACS Chem Neurosci. 2021;12:330\u20139.","journal-title":"ACS Chem Neurosci"},{"key":"454_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1021\/np8002673","volume":"71","author":"G Appendino","year":"2008","unstructured":"Appendino G, Gibbons S, Giana A, Pagani A, Grassi G, Stavri M, et al. Antibacterial cannabinoids from Cannabis sativa: a structure\u2212 activity study. J Nat Prod. 2008;71:1427\u201330.","journal-title":"J Nat Prod"},{"key":"454_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101296","volume":"14","author":"BS Basavarajappa","year":"2024","unstructured":"Basavarajappa BS, Subbanna S. Unveiling the potential of phytocannabinoids: exploring marijuana\u2019s lesser-known constituents for neurological disorders. Biomolecules. 2024;14:1296.","journal-title":"Biomolecules"},{"key":"454_CR6","doi-asserted-by":"crossref","unstructured":"Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, Di Marzo V, Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur J Pharmacol. 1998;353(1):23\u201331.","DOI":"10.1016\/S0014-2999(98)00392-6"},{"key":"454_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084204","author":"N Blebea","year":"2024","unstructured":"Blebea N, Pricopie A-I, Vlad R, Hancu G. Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25084204.","journal-title":"Int J Mol Sci"},{"key":"454_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.620021","volume":"12","author":"VD Brousseau","year":"2021","unstructured":"Brousseau VD, Wu B-S, MacPherson S, Morello V, Lefsrud M. Cannabinoids and terpenes: how production of photo-protectants can be manipulated to enhance Cannabis sativa L. phytochemistry. Front Plant Sci. 2021;12:620021.","journal-title":"Front Plant Sci"},{"key":"454_CR9","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1021\/acs.jnatprod.2c01139","volume":"86","author":"A Calcaterra","year":"2023","unstructured":"Calcaterra A, Cianfoni G, Tortora C, Manetto S, Grassi G, Botta B, et al. Natural cannabichromene (CBC) shows distinct scalemicity grades and enantiomeric dominance in Cannabis sativa strains. J Nat Prod. 2023;86:909\u201314. https:\/\/doi.org\/10.1021\/acs.jnatprod.2c01139.","journal-title":"J Nat Prod"},{"key":"454_CR10","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/s0040-4020(01)99445-1","volume":"22","author":"U Claussen","year":"1966","unstructured":"Claussen U, Spulak F, Korte F. Zur chemischen klassifizierung von pflanzen\u2014XXXI, haschisch\u2014X: Cannabichromen, ein neuer haschisch-inhalts-stoff. Tetrahedron. 1966;22:1477\u20139. https:\/\/doi.org\/10.1016\/s0040-4020(01)99445-1.","journal-title":"Tetrahedron"},{"key":"454_CR11","doi-asserted-by":"publisher","unstructured":"Dadiotis E, Cui M, Gerasi M, Mitsis V, Melliou E, Makriyannis A, Logothetis DE, Magiatis P. A simple chiral 1H NMR method for the discrimination of (R)-and (S)-cannabichromene in complex natural mixtures and their effects on TRPA1 activity. J Nat Prod. 2023;87:77\u201384.\u00a0 https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00796.","DOI":"10.1021\/acs.jnatprod.3c00796"},{"key":"454_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0306-3623(83)90004-6","volume":"14","author":"WM Davis","year":"1983","unstructured":"Davis WM, Hatoum NS. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol. Gen Pharmacol. 1983;14:247\u201352.","journal-title":"Gen Pharmacol"},{"key":"454_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S, et al. Effects of cannabinoids and cannabinoid\u2010enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163:1479\u201394.","journal-title":"Br J Pharmacol"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2010.05.019","volume":"112","author":"GT DeLong","year":"2010","unstructured":"DeLong GT, Wolf CE, Poklis A, Lichtman AH. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by \u03949-tetrahydrocannabinol. Drug Alcohol Depend. 2010;112:126\u201333.","journal-title":"Drug Alcohol Depend"},{"key":"454_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","volume":"95","author":"AT El-Alfy","year":"2010","unstructured":"El-Alfy AT, Ivey K, Robinson K, Ahmed S, Radwan M, Slade D, et al. Antidepressant-like effect of \u03949-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav. 2010;95:434\u201342.","journal-title":"Pharmacol Biochem Behav"},{"key":"454_CR16","doi-asserted-by":"publisher","unstructured":"ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. In: Kinghorn AD, Falk H, Gibbons S, Kobayashi J, editors. Phytocannabinoids: unraveling the complex chemistry and pharmacology of Cannabis sativa. Cham: Springer; 2017. p. 1\u201336. https:\/\/doi.org\/10.1007\/978-3-319-45541-9_1.","DOI":"10.1007\/978-3-319-45541-9_1"},{"key":"454_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsinfecdis.9b00419","volume":"6","author":"MA Farha","year":"2020","unstructured":"Farha MA, El-Halfawy OM, Gale RT, MacNair CR, Carfrae LA, Zhang X, et al. Uncovering the hidden antibiotic potential of cannabis. ACS Infect Dis. 2020;6:338\u201346.","journal-title":"ACS Infect Dis"},{"key":"454_CR18","doi-asserted-by":"crossref","unstructured":"Gaoni Y, Mechoulam R. Cannabichromene, a new active principle in hashish. Chem Commun (Lond). 1966;(1):20\u20131.","DOI":"10.1039\/c19660000020"},{"key":"454_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28186487","volume":"28","author":"EG Gojani","year":"2023","unstructured":"Gojani EG, Wang B, Li D-P, Kovalchuk O, Kovalchuk I. Anti-inflammatory effects of minor cannabinoids CBC, THCV, and CBN in human macrophages. Molecules. 2023;28:6487.","journal-title":"Molecules"},{"key":"454_CR20","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/metabo13030442","volume":"13","author":"RK Govindarajan","year":"2023","unstructured":"Govindarajan RK, Mishra AK, Cho K-H, Kim K-H, Yoon KM, Baek K-H. Biosynthesis of phytocannabinoids and structural insights: a review. Metabolites. 2023;13:442.","journal-title":"Metabolites"},{"key":"454_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/can.2016.0017","volume":"1","author":"A Hazekamp","year":"2016","unstructured":"Hazekamp A, Tejkalov\u00e1 K, Papadimitriou S. Cannabis: from cultivar to chemovar II\u2014a metabolomics approach to cannabis classification. Cannabis Cannabinoid Res. 2016;1:202\u201315.","journal-title":"Cannabis Cannabinoid Res"},{"key":"454_CR22","volume":"12","author":"M Hong","year":"2023","unstructured":"Hong M, Kim J-H, Han J-H, Ryu B-R, Lim Y-S, Lim J-D, et al. In vitro and in vivo anti-inflammatory potential of cannabichromene isolated from hemp. Plants (Basel). 2023;12:3966.","journal-title":"Plants (Basel)"},{"key":"454_CR23","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3390\/plants12061245","volume":"12","author":"S Hourfane","year":"2023","unstructured":"Hourfane S, Mechqoq H, Bekkali AY, Rocha JM, El Aouad N. A comprehensive review on Cannabis sativa ethnobotany, phytochemistry, molecular docking and biological activities. Plants Basel. 2023;12:1245.","journal-title":"Plants Basel"},{"key":"454_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02674-8","volume":"11","author":"Y-N Hwang","year":"2025","unstructured":"Hwang Y-N, Park J-H, Na H-H, Kwon T-H, Park J-S, Chae S, et al. Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy. Cell Death Discov. 2025;11:377.","journal-title":"Cell Death Discov"},{"key":"454_CR25","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1476-5381.2012.01879.x","volume":"166","author":"AA Izzo","year":"2012","unstructured":"Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, et al. Inhibitory effect of cannabichromene, a major non\u2010psychotropic cannabinoid extracted from Cannabis sativa, on inflammation\u2010induced hypermotility in mice. Br J Pharmacol. 2012;166:1444\u201360.","journal-title":"Br J Pharmacol"},{"key":"454_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/synbio\/ysad010","volume":"8","author":"LJ Kearsey","year":"2023","unstructured":"Kearsey LJ, Yan C, Prandi N, Toogood HS, Takano E, Scrutton NS. Biosynthesis of cannabigerol and cannabigerolic acid: the gateways to further cannabinoid production,. Synth Biol. 2023;8:ysad010.","journal-title":"Synth Biol"},{"key":"454_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s42238-021-00101-0","volume":"3","author":"H Khodadadi","year":"2021","unstructured":"Khodadadi H, Salles \u00c9L, Shin E, Jarrahi A, Costigliola V, Kumar P, et al. A potential role for cannabichromene in modulating TRP channels during acute respiratory distress syndrome. J Cannabis Res. 2021;3:45.","journal-title":"J Cannabis Res"},{"key":"454_CR28","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1089\/can.2023.0049","volume":"8","author":"J Kulpa","year":"2023","unstructured":"Kulpa J, Henderson RG, Schwotzer D, Dye W, Trexler KR, McDonald J, et al. Toxicological evaluation and pain assessment of four minor cannabinoids following 14-day oral administration in rats. Cannabis Cannabinoid Res. 2023;8:S25\u201341.","journal-title":"Cannabis Cannabinoid Res"},{"key":"454_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxaf214","volume":"136","author":"PTH Kwong","year":"2025","unstructured":"Kwong PTH, Das T, Arnold JC, Chan H-K, Kwok PCL. The anti-biofilm activity of cannabinoids against methicillin-resistant Staphylococcus aureus. J Appl Microbiol. 2025;136:lxaf214.","journal-title":"J Appl Microbiol"},{"key":"454_CR30","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1124\/jpet.106.105247","volume":"318","author":"A Ligresti","year":"2006","unstructured":"Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318:1375\u201387.","journal-title":"J Pharmacol Exp Ther"},{"key":"454_CR31","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1021\/acssynbio.4c00051","volume":"13","author":"AC Love","year":"2024","unstructured":"Love AC, Purdy TN, Hubert FM, Kirwan EJ, Holland DC, Moore BS. Discovery of latent cannabichromene cyclase activity in marine bacterial flavoenzymes. ACS Synth Biol. 2024;13:1343\u201354.","journal-title":"ACS Synth Biol"},{"key":"454_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-019-0978-9","volume":"567","author":"X Luo","year":"2019","unstructured":"Luo X, Reiter M, d\u2019Espaux L, Wong J, Denby C, Lechner A, et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature. 2019;567:123\u20136. https:\/\/doi.org\/10.1038\/s41586-019-0978-9.","journal-title":"Nature"},{"key":"454_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/07352689.2016.1265363","volume":"35","author":"RC Lynch","year":"2016","unstructured":"Lynch RC, Vergara D, Tittes S, White K, Schwartz CJ, Gibbs MJ, et al. Genomic and chemical diversity in cannabis. CRC Crit Rev Plant Sci. 2016;35:349\u201363.","journal-title":"CRC Crit Rev Plant Sci"},{"key":"454_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","volume":"162","author":"S Maione","year":"2011","unstructured":"Maione S, Piscitelli F, Gatta L, Vita D, De Petrocellis L, Palazzo E, et al. Non\u2010psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. Br J Pharmacol. 2011;162:584\u201396.","journal-title":"Br J Pharmacol"},{"key":"454_CR35","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1021\/acs.jnatprod.4c00861","volume":"87","author":"S Manetto","year":"2024","unstructured":"Manetto S, Caprioglio D, Grassi G, Botta B, Gasparrini F, Mazzoccanti G, et al. Cannabichromene (CBC) shows matrix-dependent thermal configurational stability. J Nat Prod. 2024;87:2724\u20139.","journal-title":"J Nat Prod"},{"key":"454_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bcpt.13943","volume":"134","author":"D Marsh","year":"2023","unstructured":"Marsh D, Sugiyama A, Imai Y, Kato R, Smid S. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid \u03b2\u2010evoked neurotoxicity and changes in cell morphology in PC12 cells. Basic Clin Pharmacol Toxicol. 2023;134:293\u2013309. https:\/\/doi.org\/10.1111\/bcpt.13943.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"454_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/bcpt.13943","volume":"134","author":"DT Marsh","year":"2024","unstructured":"Marsh DT, Sugiyama A, Imai Y, Kato R, Smid SD. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid \u03b2\u2010evoked neurotoxicity and changes in cell morphology in PC12 cells. Basic Clin Pharmacol Toxicol. 2024;134:293\u2013309.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"454_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1039\/a703973e","volume":"16","author":"R Mechoulam","year":"1999","unstructured":"Mechoulam R, Ben-Shabat S. From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis. Nat Prod Rep. 1999;16:131\u201343.","journal-title":"Nat Prod Rep"},{"key":"454_CR39","doi-asserted-by":"publisher","unstructured":"Moore CF, Weerts EM, Kulpa J, Schwotzer D, Dye W, Jantzi J, Bonn-Miller MO. Pharmacokinetics of oral minor cannabinoids in blood and brain. Cannabis Cannabinoid Res. 2023;8(1_suppl):S51\u201361. https:\/\/doi.org\/10.1089\/can.2023.0066.","DOI":"10.1089\/can.2023.0066"},{"issue":"6","key":"454_CR40","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/s0031-9422(98)00278-7","volume":"49","author":"S Morimoto","year":"1998","unstructured":"Morimoto S, Komatsu K, Taura F, Shoyama Y. Purification and characterization of cannabichromenic acid synthase from Cannabis sativa. Phytochemistry. 1998;49(6):1525\u20139. https:\/\/doi.org\/10.1016\/s0031-9422(98)00278-7.","journal-title":"Phytochemistry"},{"key":"454_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00487","author":"C Muller","year":"2019","unstructured":"Muller C, Morales P, Reggio P. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnmol.2018.00487.","journal-title":"Front Mol Neurosci"},{"key":"454_CR42","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jnatprod.1c00976","author":"T Ohtsuki","year":"2022","unstructured":"Ohtsuki T, Friesen J, Chen S, McAlpine J, Pauli G. Selective preparation and high dynamic-range analysis of cannabinoids in \u201cCBD oil\u201d and other Cannabis sativa preparations. J Nat Prod. 2022. https:\/\/doi.org\/10.1021\/acs.jnatprod.1c00976.","journal-title":"J Nat Prod"},{"key":"454_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30040758","author":"A Owolabi","year":"2025","unstructured":"Owolabi A, Ogunsola O, Joens E, Kotler M, Song L. A systematic study of liquid chromatography in search of the best separation of cannabinoids for potency testing of hemp-based products,. Molecules. 2025. https:\/\/doi.org\/10.3390\/molecules30040758.","journal-title":"Molecules"},{"key":"454_CR44","doi-asserted-by":"publisher","first-page":"S547","DOI":"10.1097\/SAP.0000000000003518","volume":"90","author":"JF Palacios","year":"2023","unstructured":"Palacios JF, Hazkour N, Robinson E, Swami P, Smith L, Grande D, et al. Primary ear reconstruction using cadaveric costal cartilage. Ann Plast Surg. 2023;90:S547\u201351.","journal-title":"Ann Plast Surg"},{"key":"454_CR45","doi-asserted-by":"publisher","unstructured":"S.P. Pant, S. Joshi, D. Bisht, M. Bisht, Exploring the historical, botanical, and taxonomical foundations of cannabis: A review, Cannabis and Its Derivatives. 2024;3\u201336. https:\/\/doi.org\/10.1016\/B978-0-443-15489-8.00001-3.","DOI":"10.1016\/B978-0-443-15489-8.00001-3"},{"key":"454_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00228-021-03232-8","volume":"78","author":"EN Peters","year":"2022","unstructured":"Peters EN, MacNair L, Mosesova I, Christians U, Sempio C, Klawitter J, et al. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and \u03949-tetrahydrocannabinol: a pilot study. Eur J Clin Pharmacol. 2022;78:259\u201365.","journal-title":"Eur J Clin Pharmacol"},{"key":"454_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x1801300922","author":"F Pollastro","year":"2018","unstructured":"Pollastro F, Caprioglio D, Del Prete D, Rogati F, Minassi A, Taglialatela\u2010Scafati O, et al. Cannabichromene. Nat Prod Commun. 2018. https:\/\/doi.org\/10.1177\/1934578x1801300922.","journal-title":"Nat Prod Commun"},{"key":"454_CR48","doi-asserted-by":"publisher","DOI":"10.1021\/acssynbio.4c00721","author":"M Qi","year":"2025","unstructured":"Qi M, Liu T, Zhang W, Wan H, Wang M, Kang W, et al. Enhancing cannabichromenic acid biosynthesis in Saccharomyces cerevisiae. ACS Synth Biol. 2025. https:\/\/doi.org\/10.1021\/acssynbio.4c00721.","journal-title":"ACS Synth Biol"},{"key":"454_CR49","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/bit.26932","volume":"116","author":"S Qian","year":"2019","unstructured":"Qian S, Clomburg JM, Gonzalez R. Engineering Escherichia coli as a platform for the in vivo synthesis of prenylated aromatics. Biotechnol Bioeng. 2019;116:1116\u201327.","journal-title":"Biotechnol Bioeng"},{"key":"454_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010083","volume":"12","author":"WM Raup-Konsavage","year":"2023","unstructured":"Raup-Konsavage WM, Sepulveda DE, Wang J, Dokholyan NV, Vrana KE, Graziane NM. Antinociceptive effects of cannabichromene (CBC) in mice: insights from von Frey, tail-flick, formalin, and acetone tests. Biomedicines. 2023;12:83.","journal-title":"Biomedicines"},{"key":"454_CR51","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bph.12120","volume":"169","author":"B Romano","year":"2013","unstructured":"Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio MG, et al. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol. 2013;169:213\u201329.","journal-title":"Br J Pharmacol"},{"key":"454_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202300507","volume":"19","author":"C Schmidt","year":"2024","unstructured":"Schmidt C, Aras M, Kayser O. Engineering cannabinoid production in Saccharomyces cerevisiae,. Biotechnol J. 2024;19:2300507. https:\/\/doi.org\/10.1002\/biot.202300507.","journal-title":"Biotechnol J"},{"key":"454_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202300507","author":"C Schmidt","year":"2024","unstructured":"Schmidt C, Aras M, Kayser O. Engineering cannabinoid production in Saccharomyces cerevisiae,. Biotechnol J. 2024. https:\/\/doi.org\/10.1002\/biot.202300507.","journal-title":"Biotechnol J"},{"key":"454_CR54","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1124\/jpet.124.002166","volume":"391","author":"DE Sepulveda","year":"2024","unstructured":"Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, et al. The potential of cannabichromene (CBC) as a therapeutic agent. J Pharmacol Exp Ther. 2024;391:206\u201313. https:\/\/doi.org\/10.1124\/jpet.124.002166.","journal-title":"J Pharmacol Exp Ther"},{"key":"454_CR55","doi-asserted-by":"publisher","first-page":"15611","DOI":"10.1007\/s00210-025-04236-2","volume":"398","author":"A Sharma","year":"2025","unstructured":"Sharma A, Singh R, Virmani T, Chouhan NK, Kapoor G, Kumar G, et al. Cannabichromene, a key non-psychotropic phytocannabinoid in treatment of major depressive disorder: in silico and in vivo explorations. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:15611\u201330.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"454_CR56","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/10826076.2019.1663529","volume":"42","author":"J Sherma","year":"2019","unstructured":"Sherma J, Rabel F. Thin layer chromatography in the analysis of cannabis and its components and synthetic cannabinoids. J Liq Chromatogr Relat Technol. 2019;42:613\u201328.","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"454_CR57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.neuint.2013.08.002","volume":"63","author":"N Shinjyo","year":"2013","unstructured":"Shinjyo N, Di Marzo V. The effect of cannabichromene on adult neural stem\/progenitor cells. Neurochem Int. 2013;63:432\u20137.","journal-title":"Neurochem Int"},{"key":"454_CR58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1089\/can.2023.0052","volume":"9","author":"JLQ Simei","year":"2024","unstructured":"Simei JLQ, Souza JDR, Lisboa JR, Campos AC, Guimar\u00e3es FS, Zuardi A, et al. Does the \u201centourage effect\u201d in cannabinoids exist? A narrative scoping review. Cannabis & Cannabinoid Research. 2024;9:1202\u201316.","journal-title":"Cannabis & Cannabinoid Research"},{"key":"454_CR59","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1089\/can.2023.0052","volume":"9","author":"JLQ Simei","year":"2024","unstructured":"Simei JLQ, Souza JDR, Lisboa JR, Campos AC, Guimar\u00e3es FS, Zuardi A, et al. Does the \u201centourage effect\u201d in cannabinoids exist? A narrative scoping review. Cannabis Cannabinoid Res. 2024;9:1202\u201316.","journal-title":"Cannabis Cannabinoid Res"},{"key":"454_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092280","author":"A Stasi\u0142owicz-Krzemie\u0144","year":"2023","unstructured":"Stasi\u0142owicz-Krzemie\u0144 A, Szulc P, Cielecka\u2010Piontek J. Co-dispersion delivery systems with solubilizing carriers improving the solubility and permeability of cannabinoids (cannabidiol, cannabidiolic acid, and cannabichromene) from Cannabis sativa (Henola variety) inflorescences,. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15092280.","journal-title":"Pharmaceutics"},{"key":"454_CR61","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.toxrep.2023.06.001","volume":"10","author":"OA Taiwo","year":"2023","unstructured":"Taiwo OA, Dosumu OA, James AS, Ugwor EI, Ojo OA, Dedeke GA, et al. Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites. Toxicol Rep. 2023;10:690\u2013705.","journal-title":"Toxicol Rep"},{"key":"454_CR62","doi-asserted-by":"publisher","unstructured":"Udoh M, Santiago M, Devenish S, McGregor IS, Connor M. Cannabichromene is a cannabinoid CB2 receptor agonist. Br J Pharmacol. 2019;176(23):4537\u201347. https:\/\/doi.org\/10.1111\/bph.14815.","DOI":"10.1111\/bph.14815"},{"key":"454_CR63","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1089\/can.2023.0212","volume":"10","author":"M Udoh","year":"2025","unstructured":"Udoh M, Santiago M, Haneef S, Rodger A, Marlowe CK, Barr PJ, et al. Activation of CB2 Receptors by (\u2212)-Cannabichromene but Not (+)-Cannabichromene. Cannabis Cannabinoid Res. 2025;10:e94\u2013101.","journal-title":"Cannabis Cannabinoid Res"},{"key":"454_CR64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41467-019-08448-y","volume":"10","author":"MA Valliere","year":"2019","unstructured":"Valliere MA, Korman TP, Woodall NB, Khitrov GA, Taylor RE, Baker D, et al. A cell-free platform for the prenylation of natural products and application to cannabinoid production. Nat Commun. 2019;10:565.","journal-title":"Nat Commun"},{"key":"454_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.777804","author":"K Walsh","year":"2021","unstructured":"Walsh K, McKinney A, Holmes A. Minor cannabinoids: biosynthesis, molecular pharmacology and potential therapeutic uses. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.777804.","journal-title":"Front Pharmacol"},{"key":"454_CR66","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/0024-3205(80)90631-1","volume":"26","author":"PW Wirth","year":"1980","unstructured":"Wirth PW, Watson ES, ElSohly M, Turner CE, Murphy JC. Anti-inflammatory properties of cannabichromene. Life Sci. 1980;26:1991\u20135.","journal-title":"Life Sci"},{"key":"454_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77175-y","volume":"10","author":"A Zagzoog","year":"2020","unstructured":"Zagzoog A, Mohamed KA, Kim HJJ, Kim ED, Frank CS, Black T, et al. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa. Sci Rep. 2020;10:20405.","journal-title":"Sci Rep"},{"key":"454_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymben.2023.10.004","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Guo J, Gao P, Yan W, Shen J, Luo X, et al. Development of an efficient yeast platform for cannabigerolic acid biosynthesis. Metab Eng. 2023. https:\/\/doi.org\/10.1016\/j.ymben.2023.10.004.","journal-title":"Metab Eng"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00454-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:02:07Z","timestamp":1791997327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00454-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00454-4","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publications","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"107"}}